文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

ECPR治疗难治性院外心脏骤停后脑死亡供者的肝移植一年存活率

One-year liver graft survival from brain-dead donors treated with ECPR for out-of-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2026-07-23
一句话结论ECPR后脑死亡供者肝移植一年存活率80%对89%,无统计学差异,但样本小不能视为等效。

单中心回顾性观察研究(2011年1月至2024年6月)纳入脑死亡并至少捐献一个器官的供者,比较ECPR治疗难治性院外心脏骤停后脑死亡供者(ECPR组)与非ECPR供者(对照组)的肝移植一年存活率。ECPR组潜在供者肝获取率39%(15/38)低于对照组79%(27/34,P<0.01);ECPR组实际肝供者更年轻(47岁对70岁),初始乳酸更高(9.4对3.0 mmol/L)。单因素分析显示一年肝移植存活率ECPR组80%(12/15,95%CI 55-93)对对照组89%(24/27,95%CI 72-96),P=0.65,无统计学差异。作者结论为无显著差异,但样本量有限,不能解释为等效。

要点

  • ECPR后脑死亡潜在供者肝获取率仅39%(15/38),显著低于非ECPR潜在供者79%(27/34),P<0.01。
  • ECPR组实际肝供者更年轻(47[36-54]岁对70[48-79]岁),但初始病情更重,峰值乳酸9.4[6.9-12.4]对3.0[2-5.7] mmol/L。
  • 单因素分析一年肝移植存活率ECPR组80%(12/15,95%CI 55-93)对对照组89%(24/27,95%CI 72-96),P=0.65。
  • 样本量有限,一年存活率无统计学差异不能解读为ECPR供者肝移植与普通供者等效。

适用人群与场景

  • 脑死亡并至少捐献一个器官的供者;ECPR组为因难治性院外心脏骤停接受ECPR后进展为脑死亡者,对照组为未接受ECPR的供者(主要为卒中及院外心脏骤停入院)。
  • 单中心回顾性观察研究,2011年1月至2024年6月。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性、单中心、观察性研究,2011年1月至2024年6月。
  • 人群:脑死亡并至少捐献一个器官的供者;ECPR组为因难治性院外心脏骤停接受ECPR后脑死亡者,对照组为未接受ECPR的供者(主要为卒中及院外心脏骤停入院)。
  • 主要终点:肝获取率ECPR组15/38(39%)对对照组27/34(79%),P<0.01。
  • 主要终点:一年肝移植存活率ECPR组12/15(80%;95%CI 55-93)对对照组24/27(89%;95%CI 72-96),单因素分析P=0.65。
  • ECPR组实际肝供者更年轻(47[36-54]岁对70[48-79]岁,P<0.01),峰值乳酸更高(9.4[6.9-12.4]对3.0[2-5.7] mmol/L,P<0.01)。

证据类型、等级与局限

  • 证据类型:回顾性、单中心、观察性研究。
  • 局限:样本量有限(ECPR组15例实际肝供者,对照组27例),作者指出无统计学差异不能解释为等效。

对床旁实践的改变

  • ECPR后脑死亡供者肝获取率较低(39%),但获取的肝移植一年存活率与对照供者无显著差异(80%对89%,P=0.65),提示此类供者肝脏可考虑用于移植,但样本小不能视为等效。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Among patients treated with extracorporeal cardiopulmonary resuscitation (ECPR) for refractory out-of-hospital cardiac arrest (OHCA), some ultimately progress to brain death and may become organ donors. This study aimed to evaluate one-year liver graft survival from donors in brain death after ECPR for refractory OHCA.

METHODS: A retrospective, single-centre, observational study was conducted between January 2011 and June 2024. All included patients were in brain death and donated at least one organ. Actual liver donors were divided into two groups: an "ECPR group" (donors treated with ECPR for refractory OHCA) and a "Control group" (donors not treated with ECPR, predominantly admitted for stroke and OHCA). The primary outcome was one-year liver graft survival.

RESULTS: Liver retrieval was performed in 15/38 (39%) potential donors treated with ECPR for refractory OHCA, compared with 27/34 (79%) potential donors not treated with ECPR (P < 0.01). Actual liver donors in the ECPR group were younger (47 [36-54] vs. 70 [48-79] years, P < 0.01) with greater initial severity: for instance peak lactate was higher (9.4 [6.9-12.4] vs. 3.0 [2-5.7] mmol/L, P < 0.01). In univariate analysis, one-year liver graft survival did not differ significantly between groups: 12/15 (80%; 95% CI, 55-93) in the ECPR group vs. 24/27 (89%; 95% CI 72-96) in the control group, (P = 0.65).

CONCLUSION: There was no statistically significant difference in one-year liver graft survival between donors treated with ECPR for refractory OHCA and other donors. Given the limited sample size, this lack of statistical significance should not be interpreted as evidence of equivalence.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Raphalen JH, Soumagnac T, Merle-Beral R, et al. One-year liver graft survival from brain-dead donors treated with ECPR for out-of-hospital cardiac arrest. Resuscitation. 2026. PMID: 42492619. doi:10.1016/j.resuscitation.2026.111219

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。